In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

Wu Kaimin was worried her dissertation proposal might not be approved. Now, her research could fundamentally alter how ...

Received Clearance from the U.S. Food and Drug Administration (FDA) for Clinical Trials of Budoprutug in Primary Membranous Nephropathy (pMN), ...

Joining us today are Oncocyte President and CEO, Josh Riggs; Chief Science Officer, Ekke Schutz; and CFO, Andrea James. We ...

Q4 2024 Earnings Call Transcript March 24, 2025 Operator: Hello, and welcome to the Moleculin Biotech Fourth Quarter and Full ...

shortening research timelines and increasing success rates of new drug development," he said. Regulators have also improved communication channels with pharmaceutical companies, offering tailored ...

The chipmaker NVIDIA held its annual conference in Silicon Valley this week. Among the major announcements: it chose Boston ...

Here is a timeline of the company's rise and fall ... "Beyond our contracted laboratory, with which we work to process a customer's sample and deliver their results, customer information will ...

Researchers studying Alzheimer’s disease are using artificial intelligence-powered databases to accelerate the drug discovery process by making it easier to sift through vast amounts of biomedical ...

The new framework aims to shorten the time on register new medications in Israel, making drugs more readily available to the ...

New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers have now developed a technology that can be used to test around 25 antibodies ...